 Home > Biochemical Engineering > Polypeptide > Liraglutide for Sale > Liraglutide Lyophilized API Powder Bulk Wholesale Raw Material

Liraglutide Lyophilized API Powder Bulk Wholesale Raw Material

27 Inquiries

Unit Price:

$70-80/G FOB

Get Latest Price 

CAS No.:

204656-20-2

Grade:

Pharmacy Grade

Content:

92%

Port:

Shanghai/Shenzhen

Brand:

Packaging:

as require

Price valid (until):

2026-12-31

Contact Supplier

 Chat Now

XIUSHI BIOPHARMA (NANTONG) CO., LTD.

Company Type:

Manufactory

Location:

China

Payment Terms:

TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

Average Lead Time:

15 days

Qualification:

Main Products:

semaglutide,tirzepatide,liraglutide,retaturtide

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

Liraglutide

CAS NO.204656-20-2

Appearance: White Powder

Purity: ≥99%

Bacterial endotoxins:<10EU/mg

ECHEMI Editorial Reference

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of～10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

Basic Info

Product Name:

Liraglutide

Other Name:

Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

CAS No.:

204656-20-2

Molecular Formula:

C172H265N43O51

InChIKeys:

YSDQQAXHVYUZIW-VTFFJMQZNA-N

Molecular Weight:

3751.202

Exact Mass:

3748.95000

EC Number:

810-818-7

Color/Form:

White to Off-White

Categories:

Polypeptide

Characteristics

PSA:

1513.76000

XLogP3:

6.12960

Melting Point:

>182°C (dec.)

Critical Temperature & Pressure:

Refrigerator

Research

Class:

GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

Status:

FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

Mechanism:

A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

EC50 (GLP1R Ec50):

~10 nM

Source:

DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

Clinical Development:

NCT00781922; NCT01272219

FDA:

Victoza, Saxenda (approved 2010-01-25)

References

ChEMBL:

CHEMBL1213363

DrugBank:

DB06655

KEGG DRUG:

D09199

PubChem:

PubChem

Literature:

FDA: Victoza (NDA 022341); NEJM: Marso et al. (2016) — LEADER CV outcomes

Disclaimer:

Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

See More Liraglutide Properties 

Hazard Identification

Classification of the substance or mixture

Carcinogenicity, Category 2

Reproductive toxicity, Category 2

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Warning
Hazard statement(s)	H351 Suspected of causing cancer H361 Suspected of damaging fertility or the unborn child
Prevention	P203 Obtain, read and follow all safety instructions before use. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response	P318 IF exposed or concerned, get medical advice.
Storage	P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More Liraglutide Safety Data Sheet 

Seller Information

Business Type:
Manufactory

Main Products:
semaglutide,tirzepatide,liraglutide,retaturtide

Location:
No.109 Yongfu Road, Chongchuan District, Nantong, Jiangsu Province,226000 China

Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
15 days

Total Annual Revenue:
$10 million-$25 million

Total Employees:
101-200

Year of Establishment:
2020

Company Certificates
- ISO 9001
- semaglutide US DMF
Company Profile
Xiushi Biopharma is an international leading high-tech enterprise focusing on large-scale biosynthesis of polypeptide drugs. We provide all-round products and services from drug research, clinical development to access to market for global biotechnology and pharmaceutical enterprises.

We have professional and experienced engineers and scientists, providing new polypeptide drug biosynthesis solutions, which help partners stay ahead of the polypeptide drug discovery, clinical development and market production.
We have more than 5000 square meters of R&D center and 20000 square meters of intelligent manufacturing base, which can meet the needs of different customers and products, while meeting the GMP conditions for drug production.
XIUSHI Biopharma is a CDMO specializing in the manufacturing of synthetic peptides and oligonucleotides for early-phase, late-phase development, and commercial production. XIUSHI Biopharma excels in large-scale, late-phase, and commercial production, boasting the production capability in kgs quantities.
We specialize in contract development and manufacturing organization ("CDMO") services, which include peptide chemistry, manufacturing, and controls ("CMC") development; as well as contract manufacturing organization ("CMO") services, encompassing peptide new chemical entities (NCEs) and generic drug commercial manufacturing.
XIUSHI Biopharma provides a comprehensive peptide-centric CDMO platform with vertically integrated capabilities in peptide drug development and manufacturing, adhering strictly to Good Manufacturing Practice (GMP) standards mandated by major regulatory authorities globally.
GMP Compliance
XIUSHI Biopharma's GMP program strictly adheres to FDA/EU GMP guidelines.

Inquiry History

27 Inquiries

Country	Product	Purchase Quantity	Date Posted
India	Liraglutide	1.00 KG	Oct 8, 2024
India	Liraglutide-USP	150.00 G	Oct 10, 2023
United States	MIC	2 MT	May 20, 2026
United States	liraglutide	1	Jan 21, 2026
Canada	Liraglutide	1 KG	Dec 8, 2025
Brazil	Liraglutida	1 G	Sep 29, 2025
United States	Liraglutide	1 KG	Aug 13, 2025
Sweden	liraglutide	1 KG	Aug 4, 2025
Turkey	Liraglutide	5 MG	Jul 4, 2025
Reunion Island	Liraglutide	1 G	Apr 14, 2025
Pakistan	liraglutide	500 MG	Feb 19, 2025
India	Liraglutide	100.00 KG	Nov 7, 2023
South Korea	Liraglutide	1 G	Sep 19, 2026
United Kingdom	Liraglutide	20 MG	Jul 8, 2026
United States	Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta	50 MG	Mar 4, 2026
United States	liraglutide	1 MT	Nov 22, 2025
Pakistan	liraglutide injection	50 KG	Jan 21, 2025
India	Liraglutide	10 MG	Jul 17, 2024
India	liraglutide	1 KG	Feb 25, 2026
United States	Liraglut	1 MT	Feb 9, 2025

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Liraglutide LL5 LL10 LL30 CAS:204656-20-2 Factory Supply Pharmaceutical Grade 99% Liraglutide Powder	Pharmaceutical Grade/99	$33-36/UNIT FOB	Jielu Trading	Inquiry
Liraglutide high pure 99% raw material powder CAS 204656-20-2	Pharmaceutical Grade/99	$1/G FOB	Hubei Meisang Trading Co.,Ltd	Inquiry
Liraglutide CAS: 204656-20-2 High quality products. 99% white powder, factory price	Pharmaceutical Grade/99	$90-100/UNIT FOB	LingMi BioTechnology Co., Ltd	Inquiry
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer.	Research Grade/99	$50/UNIT FOB	PGpeptides	Inquiry
Liraglutide CAS 204656-20-2 Synthetic GLP-1 Analog Research Peptide, 99% High Purity Lyophilized Powder with Complete COA, For Lab Research Only	Pharmaceutical Grade/99	$82-101/UNIT FOB	Shanxi Xinghengyuan Technology and Trade Co., Ltd.	Inquiry

Liraglutide Lyophilized API Powder Bulk Wholesale Raw Material

Product Description

Seller Information